Cancer Patient Success Prompts Cannabis Science To Begin FDA Investigational New Drug (IND) Application Process

Jan 28, 2012 by

A pioneering U.S. biotech company developing pharmaceutical cannabis (marijuana) products, is pleased to inform that the current progress and success with their numerous self-medicated cancer patients, has lead the Company to immediately begin the Investigational New Drug (IND) application process that will target cancer treatment.


Cannabis Science is currently tracking numerous cancer patients, who are self-medicating with cannabis extracts. The Company has evident success with these patients, which creates support to submit an IND application to the FDA. The prescription pharmaceutical market is the number one target market for Cannabis Science, and with having the appropriate backup for the application process, it is all very promising for the Company and cancer patients worldwide.

Other Posts You May Be Interested In

From around the web Tagged with: cancer patientsCannabis ScienceFDA Investigational New DrugINDInvestigational New DrugPromptsscienceSuccessthe Company

About the author

Assistant Editor - Mindscape magazine.



Google Plus

Follow Me on Pinterest
  • More believe aliens than god.

    Pinned: 19 Oct 2012
  • Study recommends decriminilisation of drugs.

    Pinned: 15 Oct 2012
  • Life on moons easier to find?

    Pinned: 11 Oct 2012
  • Man falls to Earth from 23 miles up.

    Pinned: 9 Oct 2012
  • Simon Singh under attack for criticisng health magazine.

    Pinned: 4 Oct 2012
  • Jail time for another banker.

    Pinned: 22 Sep 2012
  • ATOS inhumane puppets of a sick government. This has to stop.

    Pinned: 22 Sep 2012
  • Strange rock on mars

    Pinned: 20 Sep 2012
  • Jesus said he was married

    Pinned: 19 Sep 2012
  • Bees reboot brain to accomplish different tasks.

    Pinned: 17 Sep 2012